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Abstract Defective antigen presentation by HIV-infected 
monocytes is related to severe immune dysfunction in patients 
with AIDS, although the mechanism by which this process occurs 
is not well defined. Here we report that reduced capacity by 
HIV-infected monocytes to stimulate or present antigen to 
CD4+ T-cells was mediated by cellular factors associated with 
the plasma membranes of HIV-infected monocytes. In contrast, 
soluble factors secreted by HIV-infected monocytes had little or 
no effect on T-cell stimulation. Reduced T-cell stimulation by 
H! V-infected monocytes was related to down-modulation of CD4 
expression on helper T-cells and was not affected by the inclusion 
of anti-HIV-gpl20 Ab, indicating the involvement of soluble or 
cell-associated viral envelope protein to be less likely. Exposure 
of CD4+ T-cells, that had been in co-culture with HIV-infected 
monocytes, to uninfected monocytes partially restored impaired 
T-cell stimulation. Thus, for the first time we report that altered 
capacity of HIV-infected monoeytes to stimulate and present 
antigen to CD4+ T-cells is related to down-modulation of CD4 
expression on T-cells, and appears to occur via membrane- 
associated cellular factors on HIV-infected monocytes. 
K~ v words." HIV; AIDS;  Monocyte; T-cell; Antigen 
pr,'sentation 
I. Introduction 
vlonocytes play an important role in the pathogenesis of 
HIV infection [1 3]. These cells serve as virus reservoir in 
aft,rated tissues, vectors for virus transmission to the central 
nervous system, and potent source of inflammatory cytokines 
which can affect tissue function and virus replication [4,5]. In 
addition to being major target cells for HIV infection, mono- 
cytes also play a critical role as antigen presenting cells which 
allows antigen recognition and proliferation of CD4+ T-cells 
[6] Previous studies on peripheral blood monocytes from 
HI V-infected patients and in vitro have demonstrated defects 
in antigen presentation by monocytes [7-11]. Although hu- 
m~rral responses have been reported to be normal, the ability 
to respond to antigens is diminished with the progression of 
the disease [12,13]. The basis for unresponsiveness of CD4+ 
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Ab/,reviations." MOI, multiplicity of infection; MLR, mixed leukocyte 
reaction; HIV, human immunodeficiency virus; AIDS, acquired 
immunodeficiency syndrome; TCR, T-cell receptor; Ag, antigen. 
T-cells to antigen which may contribute to dysregulation of 
immune function seen during the course of HIV disease is, 
therefore, important o study. In the present study, we have 
examined the involvement of viral and cellular components 
associated with HIV-infected monocytes on the ability of 
these cells to stimulate and present antigen to CD4+ T-cells. 
We have demonstrated that altered accessory function of 
HIV-infected monocytes is associated with down-modulation 
of CD4 expression on helper T-cells and is mediated, at least 
in part, by cell membrane-associated factors. 
2. Materials and methods 
2.1. Isolation and HIV infection of monocytes 
Monocytes were purified from PBMC of donors seronegative for 
HIV and hepatitis B infection after leukapheresis and purified by 
countercurrent centrifugal elutriation [14]. Cell suspensions contained 
> 95% monocytes by criteria of cell morphology on Wright-stained 
cytosmears, by granular peroxidase, and by non-specific esterase. 
After 5-7 days of culture, monocytes in 96-well plastic plates, were 
exposed to HIV-IADA, a monocytotropic HIV strain (Advanced Bio- 
technologies Inc., Columbia, MD) at the desired multiplicity of infec- 
tion (MOI), infectious virus/target cell [15]. After a 2 h viral adsorp- 
tion interval, cultures were washed and refed with fresh medium. 
Culture medium was half-exchanged with fresh medium every 2 3 
days. 
2.2. Preparation of monocyte membranes 
Membranes from monocytes were prepared according to the meth- 
od of Lin et al. [16]. All steps were carried out at 4°C unless otherwise 
indicated. Briefly, cultured, uninfected and HIV-infected monocytes 
were washed three times with PBS, resuspended in 50 mM mannitol 
(Sigma Chemical Co., St. Louis, MO) containing 5 mM HEPES, and 
a cocktail of protease inhibitors (consisting of 1 mM PMSF, 10 ~tM 
pepstatin A, 10 ~tM antipain, 10 ~tM leupeptin, and 10 ~M chymo- 
statin), pH 7.4, and sonicated to disrupt cells. CaCI2 was added to a 
final concentration of 10 mM and incubated at 4°C for 20 min with 
gentle rotation. The homogenate was centrifuged at 5000xg for 10 
min to remove nuclei and calcium-induced membrane aggregates. The 
supernatant containing plasmalemma vesicles was further centrifuged 
for 1 h at 48 000 x g to isolate plasma membrane in an ultracentrifuge 
(Beckman Instruments). The translucent membrane pellet was washed 
twice with PBS, and resuspended in DMEM by triturating with a 1 ml 
syringe in polypropylene tube freeze vials and stored under nitrogen at 
-80°C until used. 
2.3. Preparation of CD4+ T-cell population 
Total T-cell population was obtained by elutriation [14]. Residual 
accessory cells were removed by plastic adherence for monocytes fol- 
lowed by panning on anti-Ig-coated plastic plates for B-cells. This T- 
cell enriched population was used to further purify CD4+ T-cells by 
depleting CD8+ T-cells using columns immobilized with anti-CD8 
mAb according to the protocol suggested by the manufacturer (Pierce 
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Fig. 1. Effect of HIV infection on monocyte-induced T-cell stimulation and antigen presentation to CD4+ T-cells. (A) Freshly isolated CD4+ 
T-cells (106 cells/well) were added to monocytes, and incubated at 37°C for 72 h. T-cell proliferation was determined by [3H]thymidine incor- 
poration as described in Section 2. (a) T-cell stimulation by monocytes infected with HIV at various MOI; (b) T-cell stimulation by monocytes 
infected with HIV at various times after infection. (©) +antigen; (e) -antigen. (B) (a) Uninfected or HIV-infected monocytes were fixed with 
4% paraforrnaldehyde for 2 h, washed with PBS, and incubated with CD4+ T-cells; (b) CD4+ T-cells were incubated with plasma membranes 
from uninfected (open bar) or HIV-infected monocytes (hatched bar); (c) T-cell stimulation by monocytes in the presence of culture fluid from 
uninfected (open bar) or HIV-infected monocytes (hatched bar); (d) stimulation by uninfected (open bar) or HIV-infected monocytes (hatched 
bar) of T-cells separated by a transwell system. The data are representative of three experiments. 
Chemical Co., Rockford, IL). The CD4+ enriched T-cell population 
(> 98%) thus obtained was used for T-cell proliferation assays. 
2.4, T-cell proliferation assay 
Uninfected and HIV-infected monocytes (105 cells/0.2 ml) were in- 
cubated in the presence or absence of tetanus toxoid (500 ng/ml) for 2 
h, washed with DMEM, and then were co-incubated with CD4+ T- 
cells (106 cells/well) for 3 days. T-cell proliferation was measured by 
the uptake of [3H]thymidine (20 Ci/mM, New England Nuclear, Bos- 
ton, MA) which was added (1 IxCi/well) on the third day of culture. 
Cells were harvested 16 h later using a Millipore multiscreen vacuum 
manifold with type C glass fiber filter plates (Millipore, Bedford, MA) 
and incorporated radioactivity was measured using a liquid scintilla- 
tion counter. 
2.5. Detection of CD4 and CD8 expression on T-cells by flow 
eytometry 
CD4 or CD8 expression on T-cell population was determined by 
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Fig 2. Effect of anti-gpl20 Ab on monocyte-induced T-cell stimulation. (A) Monocytes infected with HIV at various MOI were incubated with 
C17:,4+ T-cells in the presence or absence of polyclonal anti-gpl20 Ab (50 gg/ml), and T-cell proliferation was determined asdescribed in Sec- 
tio~ 2. (B) Recovery of reduced T-cell proliferation by uninfected monocytes. CD4+ T-cells in co-culture with HIV-infected monocytes for 
3 days were added to uninfected monocytes, incubated for 3 additional days, and T-cell proliferation was determined asdescribed in Section 2. 
Opm bar, stimulation by HIV-infected monocytes of T-cells that had been in co-culture with HIV-infected monocytes for 3 days; hatched bar, 
stirmlation by uninfected monocytes ofT-cells that had been in co-culture with HIV-infected monocytes for 3 days. 
flow cytometry according to a protocol described earlier for p24 de- 
tection [17] with slight modifications. Briefly, purified T-cells, total T- 
cell~ or PBMC co-cultured with uninfected or HIV-infected mono- 
cyl es after 3 days of incubation were recovered, washed twice with 
PBq, and resuspended in binding buffer (PBS containing 2% FBS, 
0.2/0 BSA, 0.2% NAN3, and 1 mg/ml human immunoglobulins). Cells 
were then incubated with CD3-FITC/CD4-PE or CD3-FITC/CD8-PE 
mAb (Becton Dickinson, Mountain View, CA) for 30 min at 4°C. 
Ceils were then washed twice with cold PBS, fixed in 4% paraformal- 
deY yde, and examined by flow cytometry (Becton Dickinson). 
3. Results 
Fhe ability of monocytes after HIV infection to stimulate 
and present antigen to CD4+ T-cells was examined by a 
mi~ed leukocyte reaction (MLR) assay. Monocytes were in- 
fected with HIV at various MOI, and co-incubated with 
C1)4+ T-cells in the present or absence of tetanus toxoid 
(5q~0 ng/ml) for 3 days. T-cell stimulation was determined by 
[al []thymidine incorporation i  T-cells. HIV-infected mono- 
cyles at various MOI resulted in a significant reduction of 
T-cell proliferation as shown in Fig. 1A. Consistently, HIV 
inlection of monocytes also reduced their ability to present 
antigen to CD4+ T-cells (Fig. 1A,a). Similar results were ob- 
tained when CD4+ T-cells were co-incubated with HIV-in- 
fected monocytes at various times after infection (Fig. 
1A,b). Thus, the reduced capacity of HIV-infected monocytes 
to stimulate CD4+ T-cells was directly related to viral load in 
th~ infected monocytes. Reminiscent with the findings of Fig. 
1A, HIV-infected monocytes after fixation with 4% parafor- 
maldehyde as well as cell membranes from infected cells also 
demonstrated reduced T-cell proliferation by more than 2-fold 
(Fig. 1B; a and b, respectively). In contrast, cell-free culture 
flud from uninfected or HIV-infected monocytes had no ef- 
fect on monocyte-induced T-cell proliferation (Fig. 1B,c). 
Similarly, no induction of T-cell proliferation was observed 
when monocytes and T-cells were separated by a 0.3 gm 
pe~'e size polycarbonate filter in a transwell system (Fig. 
1Bd), suggesting cell to cell contact o be critical for T-cell 
stimulation. 
Fo determine whether educed T-cell proliferation by HIV- 
infected monocytes was mediated by gpl20 which is expressed 
on infected cells [18], HIV-infected monocytes were incubated 
with CD4+ T-cells in the presence or absence of polyclonal 
anti-gpl20 Ab and T-cell proliferation was assayed. The in- 
clusion of excessive amounts of polyclonal anti-gpl20 Ab did 
not influence impaired T-cell stimulation (Fig. 2A), indicating 
reduced T-cell stimulation by HIV-infected monocytes was a 
process independent of CD4-gpl20 interactions. Furthermore, 
addition of soluble viral proteins HIV-gpl20 or HIV-Tat had 
no effect on resting T-cell proliferation (not shown). Thus, the 
involvement of HIV proteins in reduced T-cell proliferation 
appears less likely. To determine the ability of uninfected 
monocytes to restore impaired T-cell function, T-cells that 
had been in co-culture with HIV-infected monocytes, were 
exposed to uninfected monocyte cultures, and the ability of 
these uninfected monocytes to stimulate treated T-cells was 
assessed after 72 h. The results from these experiments shown 
in Fig. 2B clearly indicate a partial recovery in T-cell stimula- 
tion by uninfected monocytes. These results suggest he im- 
paired T-cell stimulation caused by HIV-infected monocytes 
to be a reversible phenomenon. 
CD4 plays an important role in monocyte-mediated T-cell 
stimulation [19]. To elucidate whether the reduced T-cell stim- 
ulation by HIV-infected monocytes was related to altered 
regulation of CD4 expression on T-cells, purified CD4+ T- 
cells were co-cultured with uninfected and HIV-infected 
monocytes for 72 h, and the levels of CD4 were determined 
by flow cytometry. T-cells co-cultured with HIV-infected 
monocytes exhibited down-regulation of CD4 expression 
( > 2-fold, Fig. 3a) as compared to those cultured with control 
uninfected monocytes. Similar results were obtained when to- 
tal T-cell population or PBMC were co-incubated with HIV- 
infected monocytes (Fig. 3b and d, respectively). No signifi- 
cant effect on CD8 expression was observed (Fig. 3c and e, 
respectively). Also, no differential surface HLA-DR expres- 
sion was observed between uninfected and HIV-infected 
monocytes (not shown). 
To explain a possible mechanism involved in reduced T-cell 
proliferation by HIV-infected monocytes, we have proposed a
working model depicted in Fig. 4. As shown in this model, 
HIV infection may result in the induction of host factor(s) on 
the surface of infected monocytes. These membrane-asso- 
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Fig. 3. CD4 and CD8 expression on T-cells co-cultured with uninfected or HIV-infected monocytes. CD4+ T-cells, total T-cells, or PBMC co- 
cultured with uninfected or HIV-infected monocytes for 3 days were recovered, washed 3 times with cold PBS, and incubated with CD3-FITC/ 
CD4-PE or CD3-FITC/CDS-PE mAb at 4°C for 30 min. Cells were then washed 3 times with cold PBS, fixed with 4% paraformaldehyde, and 
analyzed by flow cytometry. (a) CD4 expression on purified CD4+ T-cells; (b) CD4 expression on gated CD8-  cells in total T-cell population; 
(c) CD8 expression on gated CDS+ cells in total T-cell population; (d) CD4 expression on gated CD8-  cells in PBMC; and (e) CD8 expres- 
sion on gated CD8+ cells in PBMC. Solid lines in all histograms represent expression of CD4 or CD8 on T-cells co-cultured with uninfected 
monocytes, broken lines correspond to expression of CD4 or CD8 on T-cells co-cultured with HIV-infected monocytes, and dotted lines repre- 
sent histograms derived from T-cells stained with isotype matched control IgG. 
ciated factors on HIV-infected monocytes may down-modu- 
late CD4 expression on T-cells, and alter the interaction be- 
tween MHC class II molecules and TCR which is required for 
normal T-cell stimulation. 
4. Discussion 
Previous studies have demonstrated defects in antigen pres- 
entation by monocytes from HIV-infected individuals [7]. The 
mechanism by which HIV infection may alter the capacity of 
monocytes to stimulate T-cells, however, has remained un- 
defined so far. To understand the mechanisms involved in 
the impaired accessory function by HIV-infected monocytes, 
we have investigated how HIV infection affects the ability of 
monocytes to stimulate and present antigen to CD4+ T-cells. 
Our results indicate that reduced T-cell stimulation by HIV- 
infected monocytes was mediated by factors associated with 
monocyte membranes, and not by soluble factors secreted by 
HIV-infected cells. In addition, the fact that paraformalde- 
hyde-fixed monocytes as well as membranes from HIV-in- 
fected monocytes elicited a similar response further supports 
this notion. Therefore, it is likely that HIV-induced host fac- 
tor(s) on monocytes might alter the interactions between 
MHC-class II molecules with TCR on CD4+ T-cells required 
for T-cell stimulation, and it is so indicated as 'host factor' in 
the proposed model depicted in Fig. 4. In this proposed mod- 
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el. HIV-induced host factors may contribute to reduced T-cell 
pr)liferation by: (a) altered MHC-class II binding with TCR 
b x creating steric hindrance between these molecules; or (b) 
inducing inappropriate signaling in T-cells to down-modulate 
CI)4 molecule which supports HLA-DR-TCR interactions; or
(c both. These processes could contribute to defective im- 
m me function of CD4+ T-cells in HIV infection. To our 
krowledge, this is the first report suggesting a possible in- 
w lvement of HIV-induced host factors in viral immunopatho- 
ge aesis. 
Since monocytes from HIV-infected patients have demon- 
st~ated efective antigen presentation by monocytes with the 
pr)gression of HIV disease [7,12], we examined the accessory 
fu lction of HIV infected monocytes infected with HIV at 
various MOI, and at various times after HIV infection. We 
have demonstrated that reduced capacity of HIV-infected 
m, mocytes to stimulate and present antigens to CD4+ T-cells 
w~,s directly related to viral load in the infected monocytes. 
V~'Jth time, CD4+ T-cells in co-culture with HIV-infected 
m, mocytes were less responsive to monocyte-mediated stimu- 
lalion. Thus, consistent with the clinical observations, this 
sy,tem provides a novel model to examine the mechanisms 
in"olved in the altered accessory function of HIV-infected 
m, ~nocytes. 
F-cells co-cultured with HIV-infected monocytes revealed 
decreased CD4 expression as compared to those cultured 
with uninfected monocytes. Similar results were obtained 
wl~en total T-cells or PBMC were incubated with HIV-in- 
fected monocytes with no significant altered CD8 expression. 
It ,s, therefore, likely that reduced T-cell proliferation may be 
due to an insufficient level of CD4 molecule required to sup- 
pert HLA-DR-TCR interactions as shown in Fig. 4. We next 
ex tmined the likelihood of HLA-DR dysregulation on mono- 
c) es that could also alter their interactions with TCR on 
Cl)4+ T-cells, and reduce their ability to stimulate T-cells. 
OL~r data, however, indicate no significant difference in the 
level of HLA-DR between uninfected and HIV-infected 
m~,nocytes (not shown). These findings are consistent with 
th,}se reported earlier by other investigators [20]. Thus, the 
inability of HIV-infected monocytes to stimulate CD4+ T- 
cells may not be due to altered HLA-DR expression on in- 
fected monocytes. 
To investigate whether educed T-cell proliferation by HIV- 
infected monocytes was due to participation of gpl20 ex- 
pressed on the surface of HIV-infected monocytes [18], we 
examined the ability of anti-HIV-gpl20 Ab to block this ef- 
fect. Our results indicate that inclusion of anti-gpl20 Ab in 
MLR had no effect on HIV-infected monocyte-induced re-
duced T-cell proliferation, indicating the possible involvement 
of viral gpl20 to be less likely. The proposed role of mem- 
brane-associated molecules on HIV-infected monocytes for 
reduced T-cell proliferation was supported by experiments 
where the membranes i olated from infected monocytes or 
paraformaldehyde-fixed monocytes elicited immune responses 
in T-cells similar to those induced by monocytes productively 
infected with HIV. This concept was further supported by 
experiments where uninfected monocytes partially restored 
stimulation of T-cells that had been co-cultured with HIV- 
infected monocytes. These results indicate that defective T- 
cell response to HIV-infected monocytes may be a reversible 
phenomenon. Thus, based on these observations, it is reason- 
able to hypothesize that HIV-induced cellular factors may 
transduce inappropriate signaling in helper T-cells resulting 
in the defective immune response. However, additional experi- 
mental evidence is needed to support his hypothesis, and is 
currently underway in. our laboratory. Furthermore, the effect 
of HIV-induced host factors on costimulation of T-cells via B- 
7/CD28 interaction which is essential for optimal T-cell stim- 
ulation [21-24], is being examined. Taken together, these 
studies may provide better insights into the mechanisms for 
dysregulation of immune system in HIV infection. 
The data presented in this report suggest that HIV infection 
of monocytes reduced their capacity to stimulate CD4+ T- 
cells. This effect was due to the involvement of cellular factors 
associated with the membrane of HIV-infected monocytes, 
and was not the result of viral or soluble factors secreted by 
infected cells. In our proposed model, HlV-infected mono- 
cytes are postulated to express HIV-induced host factors on 
their surface which can perturb monocyte-CD4+ T-cell inter- 
actions by down-modulating CD4 expression resulting in re- 
duced T-cell proliferation. Thus, continuous exposure of HIV- 
infected monocytes/macrophages with peripheral blood T-cells 
may result in altered regulation of immune function seen in 
patients with AIDS. 
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